Patent · US Active

Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid leukemias

US11752136B2 · kind B2 · utility

0Cited by

5References

10Claims

0Family size

Inventors

Daniel Starczynowski · Cincinnati, US
William Seibel · Kyles, US
Laura Barreyro · Cincinnati, US

Key dates

Filing date	Nov 21, 2022
Grant date	Sep 12, 2023
Priority date	—
Expiry date	Nov 21, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are methods for treating a myelodyspastic syndrome (MDS) and/or an acute myeloid leukemia (AML) in an individual in need thereof. Further disclosed are compositions for use in the disclosed methods, used for treating a myelodyspastic syndrome (MDS) and/or an acute myeloid leukemia (AML) in an individual in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.